510(k) Report

510(k) · Cleared

Cleared

Adaptos®Fuse Bone Graft

K253524510(k) TraditionalCleared Feb 17, 202696-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biomendex OY · MQV Filler, Bone Void, Calcium Compound

Cleared on Feb 17, 2026 as substantially equivalent to K240404 (Novabone Products, LLC, 2024) and 2 other predicates after a 96-day review. Its family tree reaches back 10 generations to 1996.

Decided
Feb 17, 2026
Review
96 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
3

Its longest line of descent runs back 10 generations to K960978 (1996). 29 ancestors in all, the oldest K852682 (1985). No later device cites it as a predicate yet.

  1. Root · 10 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 6 generations between
  3. 3 generations backK110368 Novabone Putty - Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011
  4. 2 generations backK112773 Novabne Putty Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011
  5. 1 generation backK240404 NovaBone Putty - Bioactive Synthetic Bone Graft (NB6600, NB6610…Novabone Products, LLC · 2024
  6. This deviceK253524 Adaptos®Fuse Bone GraftBiomendex OY · 2026
Show all 10 generations
  1. Root · 10 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 9 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 8 generations backK021336 Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC · 2002
  4. 7 generations backK052494 Novabone-Bioactive Synthetic GraftNovabone Products, LLC · 2005
  5. 6 generations backK080009 Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC · 2008
  6. 5 generations backK082672 Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC · 2008
  7. 4 generations backK101860 Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC · 2010
  8. 3 generations backK110368 Novabone Putty - Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011
  9. 2 generations backK112773 Novabne Putty Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011
  10. 1 generation backK240404 NovaBone Putty - Bioactive Synthetic Bone Graft (NB6600, NB6610…Novabone Products, LLC · 2024
  11. This deviceK253524 Adaptos®Fuse Bone GraftBiomendex OY · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−9K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−8K021336Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC2002—
−7K052494Novabone-Bioactive Synthetic GraftNovabone Products, LLC2005—
−6K080009Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC2008—
−5K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC2008—
−4K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC2010—
−3K110368Novabone Putty - Bioactive Synthetic Bone GraftNovabone Products, LLC2011—
−2K112773Novabne Putty Bioactive Synthetic Bone GraftNovabone Products, LLC2011—
−1K240404NovaBone Putty - Bioactive Synthetic Bone Graft (NB6600, NB6610, NB6615)Novabone Products, LLC2024—
0 (this device)K253524Adaptos®Fuse Bone GraftBiomendex OY2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198510
199310
199520
199610
199710
199810
199910
200010
200120
200210
200430
200520
200610
200710
FIG. 1 — Lineage of K253524, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K240404NovaBone Putty - Bioactive Synthetic Bone Graft (NB6600, NB6610, NB6615)
Summary page 5
…ct Code MQV Panel Orthopedic Predicates Primary Predicate NovaBone Putty – Bioactive Synthetic Bone Graft (K240404) Additoinal Predicates Synthes chronOS and chronOS Composite (K071046, K043045) NuVas…
Novabone Products, LLC2024—
*K071046Synthes Chronos Composite
Summary page 5
…icates Primary Predicate NovaBone Putty – Bioactive Synthetic Bone Graft (K240404) Additoinal Predicates Synthes chronOS and chronOS Composite (K071046, K043045) NuVasive Attrax Putty (K203714) FIBERGRAFT® BG Putty…
Synthes (Usa)2007—
*K043045Synthes (Usa) Chronos
Summary page 5
…imary Predicate NovaBone Putty – Bioactive Synthetic Bone Graft (K240404) Additoinal Predicates Synthes chronOS and chronOS Composite (K071046, K043045) NuVasive Attrax Putty (K203714) FIBERGRAFT® BG Putty (K222276)…
Synthes (Usa)2005—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 4 companies; a new generation was cleared every 2.3 years on median.
  • 1 of the 29 ancestors has a recall of any class.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Adaptos®Fuse Bone Graft is intended for use in bony voids or gaps that are not intrinsic to the stability of the bony structures. These defects may be surgically created osseous defects or defects created from traumatic injury to the bone (i.e., posterolateral spine, intervertebral disc space, and pelvis). In interbody fusion procedures, Adaptos®Fuse Bone Graft must be used with interbody fusion devices FDA cleared for use with bone void filler. Adaptos®Fuse Bone Graft Granules must be mixed with autograft prior to use. Following placement in the bony void or gap, Adaptos®Fuse Bone Graft are resorbed and replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K253524: Adaptos®Fuse Bone Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K253524

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026